I don't think that any company focused on COVID antivirals is a good investment. For any of them to be effective they have to be taken soon after symptoms begin and then you only get at most a few weeks of use. Plus they can't charge enough for the drug to make it profitable.
Given our current healthcare system the chance that you are going to be able to get a COVID antiviral in time for it to make a difference is close to nil for most people.
News 
Market Data 
Discover 
AI
